about
Lipoxins: nature's way to resolve inflammationPotential role of aspirin in the prevention of aneurysmal subarachnoid hemorrhage.The evolving role of nonsteroidal anti-inflammatory drugs in colon cancer prevention: a cause for optimismSystematic review: interactions between aspirin, and other nonsteroidal anti-inflammatory drugs, and polymorphisms in relation to colorectal cancerAssociation between MLH1 -93G>a polymorphism and risk of colorectal cancer.Association of the colorectal CpG island methylator phenotype with molecular features, risk factors, and family historyCancer Recurrence and Regional Anesthesia: The Theories, the Data, and the Future in Outcomes.NSAIDs and Colorectal Cancer Control: Promise and ChallengesNSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project.Shared Risk Factors in Cardiovascular Disease and Cancer.Chemoprevention of gastrointestinal cancer: the reality and the dream.Characterization of PPAR dual ligand MCC-555 in AOM-induced colorectal tumorigenesis.Low levels of Caspase-3 predict favourable response to 5FU-based chemotherapy in advanced colorectal cancer: Caspase-3 inhibition as a therapeutic approachExploring opportunities for colorectal cancer screening and prevention in the context of diabetes self-management: an analysis of the 2010 National Health Interview Survey.The epigenetic effects of aspirin: the modification of histone H3 lysine 27 acetylation in the prevention of colon carcinogenesis in azoxymethane- and dextran sulfate sodium-treated CF-1 mice.Identification of associations between small molecule drugs and miRNAs based on functional similarity.The neutrophil-to-lymphocyte ratio: a narrative reviewAspirin induces cell death by directly modulating mitochondrial voltage-dependent anion channel (VDAC).Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literature.Aspirin and colorectal cancer: the promise of precision chemoprevention.Lipidomics in translational research and the clinical significance of lipid-based biomarkers.Aspirin use is associated with lower indices of liver fibrosis among adults in the United States.Heat-stabilised rice bran consumption by colorectal cancer survivors modulates stool metabolite profiles and metabolic networks: a randomised controlled trial.Mechanisms of colitis-accelerated colon carcinogenesis and its prevention with the combination of aspirin and curcumin: Transcriptomic analysis using RNA-seq.Genetic polymorphisms in miRNAs and susceptibility to colorectal cancer.MTA-1 expression is associated with metastasis and epithelial to mesenchymal transition in colorectal cancer cells.Trends in the use of aspirin and nonsteroidal anti-inflammatory drugs in the general U.S. population.Exploring clinicians' attitudes about using aspirin for risk reduction in people with Lynch Syndrome with no personal diagnosis of colorectal cancer.Indomethacin sensitizes resistant transformed cells to macrophage cytotoxicity.Synergism of co-delivered nanosized antioxidants displayed enhanced anticancer efficacy in human colon cancer cell lines.Nonalcoholic fatty liver disease and hepatocellular carcinoma
P2860
Q26784376-4578AC86-BAF8-443E-9869-23A24BD4BC57Q26998381-9651DF9C-72F0-417B-9908-ED9304A898CBQ28087427-37B965D7-AF54-4A58-88E4-6BC2952BA86DQ34477434-8E58A855-039E-4DC6-AFB5-74B9483718BDQ34505399-4B852023-52E8-4C1F-941A-1E4288078C06Q35163670-C2221494-5C15-4344-85B7-E594923B723FQ35800595-97D7C4AF-4F7B-452D-8CD1-4E2FEECEC800Q36381490-160142CC-EC07-486C-9683-1BC011D54D23Q36439797-5D282E69-C059-463D-AAAF-6506779A283CQ36709155-7B6322D1-3B39-4305-8405-BCF1BFC93C6AQ36715105-B25D95BF-B234-43A2-AE67-7EEF6299FA10Q36816322-BEC7DD18-5E80-4606-84F9-EC76D172E463Q36847557-F5D5C119-62B9-4309-8E57-DB55996F0748Q37031346-6EE555FF-125C-461D-B5CB-5B87FCE8C7DAQ37220262-98859E40-8AA7-42E7-84FA-5BC8473AF3ECQ37437619-7A0922D1-B8CA-4D0B-8D60-F45505A892AFQ37573454-BF96F180-46D0-4491-AA67-292768580682Q37714891-609AD6F5-34C5-4EC4-B06A-AD4C805B73DBQ38226775-6DBDD5F5-13FF-4D98-A671-9E0CEFA3B665Q38730064-CB552E66-9383-42D7-896C-0504AA70178BQ39408952-AC9AACDB-9FD8-4AED-A383-DCC728E3F033Q40124752-1CC90FCA-CC3C-4E4F-B17D-D9E6D49D52DBQ42640845-C1A96FB9-E3FF-48EA-8F6C-5044C708EA54Q42775899-36139751-E65A-4433-A8C9-4D83693EFD65Q43486778-8BEFA6C0-3641-4412-BB99-4D37A53540E6Q44193561-C6F13DCC-0B96-4B3E-B6CD-56D9ED4416EBQ44640097-9F97EDA2-6673-4C7D-BF04-2F8C5AC59A2BQ48332941-E0054D97-59A7-4578-AA34-15DFBBD4652BQ50510470-200384A8-CE53-4647-B995-C38DED319DB3Q54943204-BDAA6EB2-CE54-4064-86B4-1484C3D635F6Q57095486-F1168E1D-85E5-472E-AECB-9183D258D6F4
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Aspirin for the prevention of colorectal cancer
@ast
Aspirin for the prevention of colorectal cancer
@en
type
label
Aspirin for the prevention of colorectal cancer
@ast
Aspirin for the prevention of colorectal cancer
@en
prefLabel
Aspirin for the prevention of colorectal cancer
@ast
Aspirin for the prevention of colorectal cancer
@en
P2860
P1476
Aspirin for the prevention of colorectal cancer
@en
P2093
X Garcia-Albeniz
P2860
P304
P356
10.1016/J.BPG.2011.10.015
P577
2011-08-01T00:00:00Z